Embody vs GoodRx Care: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Embody beats GoodRx Care overall, scoring 7.3/10 vs 6.2/10. GoodRx Care is more affordable at $119/mo vs $299/mo. Choose Embody for people who want the oral tirzepatide gum, or who'll pick the. Choose GoodRx Care for users who want fda-approved brand-name glp-1 access at marke.
A side-by-side comparison of Embody and GoodRx Care covering pricing, scores, medication types, insurance, and more to help you decide.
Embody
#38 of 48Online weight-loss program that ships compounded GLP-1 medication to your door. Run by Modern Metabolic Medicine, Inc. and prescribed through CareGLP Affiliated P.C.s, their network of licensed doctors. Two pricing plans run side by side: a promo plan starting at $99/mo for semaglutide (or $149/mo for tirzepatide) that jumps after month 1, and 'Embody Flat' at $299/mo that doesn't go up. Their standout: oral tirzepatide gum, for people who don't want to inject.
Visit EmbodyGoodRx Care
#48 of 48GoodRx Care was restructured in late 2025 from a pay-per-visit model into a telemedicine subscription: $39/mo intro rate (through January 2026) → $119/mo standard. Medication is priced aggressively: Ozempic/Wegovy $199/mo intro for the first 2 fills, then $349/mo standard. Oral Wegovy pill available at $149-199/mo.
Visit GoodRx Care| Feature | Embody | GoodRx Care |
|---|---|---|
| Our Score | 7.3/10 | 6.2/10 |
| Starting Price | $299/mo | $119/mo |
| Medication Type | Compounded | Brand |
| Insurance Accepted | No | Yes |
| Best For | People who want the oral tirzepatide gum, or who'll pick the $299/mo flat plan with eyes open instead of the teaser plan | Users who want FDA-approved brand-name GLP-1 access at market-leading subscription pricing — $199/mo Wegovy intro, $349/mo standard, plus oral Wegovy pill |
| Ranking | #38 | #48 |
Pros & Cons Compared
Embody
Pros
- +Cheap first month — $99 for semaglutide or $149 for tirzepatide. Among the lowest entry prices in the category.
- +Oral tirzepatide gum is rare. Real option for needle-phobic users. (How well it absorbs vs the FDA-approved injection isn't published.)
- +'Embody Flat' plan is $299/mo flat with no surprise increases — predictable if you pick it from the start.
- +100% money-back guarantee in writing: if you follow the program and don't see results in 6 months, they say they'll make it right.
- +Replies to every negative Trustpilot review, usually within 24 hours.
Cons
- −Recurring complaint: people sign up at $149 month 1, get billed $299–$399 in month 2. Embody admits in replies that two plans exist (promo + flat) and the switchover isn't always clear at signup.
- −Trustpilot rating is 3.3 / 5 across 46 reviews — heavily split: 41% love it, 24% give 1 star. Price is the top complaint theme.
- −Embody won't tell you which pharmacy makes the medication — just 'multiple USA certified pharmacies.' This is the norm in the category — most major brands (Embody, Henry, Hims, Yucca, Eden) don't publicly name their pharmacy partners.
- −No HIPAA disclosure on their site (HIPAA is the federal law protecting your medical info — most telehealth providers publish a statement confirming they follow it).
- −Compounded medications only — no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
- −If you stop treatment and come back, Embody's doctors will likely restart you at the lowest dose (2.5mg). It's their safety policy — some users find it overly cautious.
GoodRx Care
Pros
- +2026 subscription rewrite — $119/mo standard membership with medication priced among the lowest on the market
- +Wegovy/Ozempic intro pricing ($199/mo for first 2 fills) is market-leading for brand-name access
- +Oral Wegovy pill available at $149-199/mo — one of the cheapest oral semaglutide routes
- +Insurance accepted — GoodRx's integration with savings cards can stack with coverage
Cons
- −Model changed from pay-per-visit to subscription — users expecting à-la-carte pricing should double-check current terms
- −Compounded GLP-1s are de-emphasized on current marketing — may no longer be available
- −Subscription model means ongoing monthly fee even in maintenance months
- −Follow-up clinical care is still basic compared to dedicated GLP-1 platforms
Our Verdict
Embody edges out GoodRx Care with a score of 7.3/10 vs 6.2/10. If budget is your priority, GoodRx Care starts at $119/mo compared to Embody's $299/mo. GoodRx Care accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Embody if you want: people who want the oral tirzepatide gum, or who'll pick the $299/mo flat plan with eyes open instead of the teaser plan. Choose GoodRx Care if you want: users who want fda-approved brand-name glp-1 access at market-leading subscription pricing — $199/mo wegovy intro, $349/mo standard, plus oral wegovy pill.
Read Full Reviews
Related comparisons
Other matchups readers comparing Embody or GoodRx Care tend to look at next.
- Embody vs MyStart Health$299/mo
- Embody vs Direct Meds GLP-1$297/mo
- Embody vs Maximus$300/mo
- GoodRx Care vs Oak Longevity$130/mo
- GoodRx Care vs Ro$149/mo
- GoodRx Care vs Found$264/mo